首页 | 本学科首页   官方微博 | 高级检索  
检索        

Influence of berberine on protein tyrosine kinase of erythrocyte insulin receptors from type 2 diabetes mellitus
作者姓名:Xianglei Deng  Xinrong Li  Chenggong Tian
作者单位:[1]Center of Biochemistry, Department of Genetics and Developmental Biology, Medical College,Southeast University, Nanjing 210009, China [2]Department of Endocrinology, the Affiliated Drum Tower Hospital, Medical College of Nanjing University, Nanjing 210008, China
基金项目:Administration Bureau of Traditional Chinese Medicine of Shanxi Province(99017)
摘    要:Objective: Bererine has been used to treat type 2 diabetes mellitus in Chinese traditional medicine because of its hypoglycemic effect. In this report, we compared the intrinsic tyrosine kinase activities of erythrocyte insulin receptors from type 2 diabetes mellitus with or without stimulation by berberine in vitro. Methods- Preparations containing insulin receptors were obtained from soluble human erythrocytes, and the insulin receptors were partially purified by affinity chromatography. The tyrosine kinase activity was measured by the exogenous substrate phosphorylation. Results: Both the membrane tyrosine kinase activity and the purified receptor tyrosine kinase activity from diabetics decreased significantly compared with those of normal individuals (reduced by 67.4% and 47.2%, respectively). After incubation with berbefine, there is a statistical difference in the activity of membrane tyrosine kinase for diabetic patients ( a 150% increase). Berefine had no effect on the tyrosine kinase activity of purified insulin receptors. Conclusion: We concluded from these results that berbefine was able to improve the insulin sensitivity by increasing the protein tyrosine kinase activity of membrane-bound insulin receptors from type 2 diabetes mellitus.

关 键 词:黄连素  蛋白质  酪氨酸激酶  红细胞  胰岛素  2型糖尿病
收稿时间:2004-11-03

Influence of berberine on protein tyrosine kinase of erythrocyte insulin receptors from type 2 diabetes mellitus
Xianglei Deng,Xinrong Li,Chenggong Tian.Influence of berberine on protein tyrosine kinase of erythrocyte insulin receptors from type 2 diabetes mellitus[J].Acta Universitatis Medicinalis Nanjing,2005,19(4):181-186.
Authors:Xianglei Deng  Xinrong Li  Chenggong Tian
Abstract:Objective: Bererine has been used to treat type 2 diabetes mellitus in Chinese traditional medicine because of its hypoglycemic effect. In this report, we compared the intrinsic tyrosine kinase activities of erythrocyte insulin receptors from type 2 diabetes mellitus with or without stimulation by berberinein vitro. Methods: Preparations containing insulin receptors were obtained from soluble human erythrocytes, and the insulin receptors were partially purified by affinity chromatography. The tyrosine kinase activity was measured by the exogenous substrate phosphorylation. Results: Both the membrane tyrosine kinase activity and the purified receptor tyrosine kinase activity from diabetics decreased significantly compared with those of normal individuals (reduced by 67.4% and 47.2%, respectively). After incubation with berberine, there is a statistical difference in the activity of membrane tyrosine kinase for diabetic patients (a 150% increase). Bererine had no effect on the tyrosine kinase activity of purified insulin receptors. Conclusion: We concluded from these results that berberine was able to improve the insulin sensitivity by increasing the protein tyrosine kinase activity of membrane-bound insulin receptors from type 2 diabetes mellitus.
Keywords:type 2 diabetes mellitus  berberine  insulin receptor
本文献已被 CNKI 维普 万方数据 等数据库收录!
点击此处可从《南京医科大学学报》浏览原始摘要信息
点击此处可从《南京医科大学学报》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号